Effect of Itraconazoles on the Production of Pro-inflammatory Substances in Mouse Macrophage-like Cells

被引:1
作者
Kato, Takao [2 ]
Horie, Norio [2 ,3 ]
Hashimoto, Ken [1 ]
Satoh, Kazue [1 ,5 ]
Shimoyama, Tetsuo [2 ]
Kaneko, Tadayoshi [3 ,4 ]
Kusama, Kaoru [3 ]
Sakagami, Hiroshi [1 ]
机构
[1] Meikai Univ, Sch Dent, Dept Diagnost & Therapeut Sci, Div Pharmacol, Saitama 3500283, Japan
[2] Saitama Med Univ, Dept Oral Surg, Saitama Med Ctr, Saitama 3508550, Japan
[3] Meikai Univ, Sch Dent, Div Pathol, Saitama 3500283, Japan
[4] Tokyo Med Univ, Dept Oral & Maxillofacial Surg, Shinjyuku Ku, Tokyo 1600023, Japan
[5] Showa Univ, Sch Med, Dept Anat, Shinagawa Ku, Tokyo 1428555, Japan
来源
IN VIVO | 2010年 / 24卷 / 05期
关键词
Hydroxyitraconazole; itraconazole; macrophage; NO; PGE(2); IL-1; beta; TNF-alpha; pro-inflammatory substances; HYDROXY-ITRACONAZOLE; ANTIFUNGAL ACTIVITY; NITRIC-OXIDE; IN-VITRO;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background, Materials and Methods: Synthetic triazoles are widely used for the treatment of fun gal infection. In order to understand their possible anti-inflammatory action, we investigated the effect of itraconazole and its hydroxylated derivative (hydroxyitraconazole) on the production of various pro-inflammatory substances by mouse macrophage-like RAW264.7 cells. Results: These compounds did not apparently show any growth inhibitory or stimulatory effects over a wide range of concentrations (0.2-50 mu g/ml). Itraconazoles dose-dependently increased the production of prostaglandin E-2 (PGE(2)) and tumor necrosis factor-alpha (TNF-alpha) without affecting the production of interleukin-1 beta (IL-1 beta) and nitric oxide (NO). LPS treatment significantly enhanced the production of NO, PGE(2), TNF-alpha and IL-1 beta. The addition of itraconazoles to LPS-stimulated RAW264.7 cells significantly reduced the production of NO, but rather enhanced the production of PGE(2),TNF-alpha and IL-1 beta. ESR spectroscopy demonstrated that itraconazoles did not significantly scavenge NO and superoxide anion radicals, indicating that the inhibition of NO production by itraconazoles is not due to their radical-scavenging activity. Hydroxyitraconazole was slightly more cytostatic, and more efficiently inhibited NO production, but enhanced the production of other pro-inflammatory substances. Conclusion: These data suggest that itraconazoles regulate NO and other pro-inflammatory substances differently in activated macrophages.
引用
收藏
页码:709 / 713
页数:5
相关论文
共 13 条
[1]  
Bennett JE., 2006, Goodman Gilman's The Pharmacological Basis of Therapeutics, V11th, P1225
[2]   Paradigm lost, paradigm found: The re-emergence of hormesis as a fundamental dose response model in the toxicological sciences [J].
Calabrese, EJ .
ENVIRONMENTAL POLLUTION, 2005, 138 (03) :378-411
[3]  
Kato T, 2008, IN VIVO, V22, P583
[4]   Methodological aspects about in vitro evaluation of antioxidant properties [J].
Magalhaes, Luis M. ;
Segundo, Marcela A. ;
Reis, Salette ;
Lima, Jose L. F. C. .
ANALYTICA CHIMICA ACTA, 2008, 613 (01) :1-19
[5]   COMPARISON OF IN-VITRO ANTIFUNGAL ACTIVITY OF ITRACONAZOLE AND HYDROXY-ITRACONAZOLE BY COLORIMETRIC MTT ASSAY [J].
MIKAMI, Y ;
SAKAMOTO, T ;
YAZAWA, K ;
GONOI, T ;
UENO, Y ;
HASEGAWA, S .
MYCOSES, 1994, 37 (1-2) :27-33
[6]  
Mikami Y, 1994, CHEMOTHERAPY, V42, P290
[7]  
Miyamoto M, 2002, ANTICANCER RES, V22, P1217
[8]   Pharmacokinetics of itraconazole and hydroxyitraconazole in healthy subjects after single and multiple doses of a novel formulation [J].
Mouton, J. W. ;
van Peer, A. ;
de Beule, K. ;
Van Vliet, A. ;
Donnelly, J. P. ;
Soons, P. A. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (12) :4096-4102
[9]  
NIEWERYH M, 1999, DRUGS, V58, P238
[10]  
Noda Y, 1997, RES COMMUN MOL PATH, V96, P115